 |
|
|
| |
Five years of Treatment with Tenofovir DF for Chronic Hepatitis B Infection is Associated with Sustained Viral Suppression and
Significant Regression of Histological Fibrosis and Cirrhosis
|
| |
| |
Reported by Jules Levin
AASLD Nov 5-9 2011 SF
P. Marcellin1, M. Buti2, E.J. Gane3, Z. Krastev4, R. Flisiak5, G. Germanidis6, M.K. Washington7, C.N. Barnes8, J.F. Flaherty8, J.D. Bornstein8, J.G. McHutchison8, E.J. Heathcote9
1Hôpital Beaujon, APHP, Clichy, France, 2Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain, 3Auckland City Hospital, Auckland, New Zealand ,4University Hospital "St. Ivan Rilsky", Sofi a, Bulgaria, 5Medical University of
Bialystok, Bialystok, Poland, 6University Hospital of Thessaloniki, Thessaloniki, Greece, 7Vanderbilt University, Nashville, TN, United States, 8Gilead Sciences Inc., Foster City, CA, United States, 9University of Toronto, Toronto, ON, Canada
|
| |
|
|
|
|
|
